Envestnet Asset Management Inc. Increases Position in Zoetis Inc. $ZTS

Envestnet Asset Management Inc. raised its position in Zoetis Inc. (NYSE:ZTS) by 0.8% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,189,242 shares of the company’s stock after purchasing an additional 17,291 shares during the period. Envestnet Asset Management Inc. owned 0.49% of Zoetis worth $341,412,000 as of its most recent filing with the Securities and Exchange Commission.

Other large investors also recently modified their holdings of the company. Sound Income Strategies LLC increased its position in shares of Zoetis by 54.3% in the 2nd quarter. Sound Income Strategies LLC now owns 432 shares of the company’s stock valued at $67,000 after purchasing an additional 152 shares during the last quarter. Canoe Financial LP increased its position in shares of Zoetis by 859.0% in the 2nd quarter. Canoe Financial LP now owns 13,369 shares of the company’s stock valued at $2,085,000 after purchasing an additional 11,975 shares during the last quarter. Strs Ohio purchased a new stake in shares of Zoetis in the 1st quarter valued at approximately $22,891,000. Tandem Investment Advisors Inc. increased its position in shares of Zoetis by 100.3% in the 1st quarter. Tandem Investment Advisors Inc. now owns 395,626 shares of the company’s stock valued at $65,140,000 after purchasing an additional 198,089 shares during the last quarter. Finally, Soros Capital Management LLC boosted its holdings in shares of Zoetis by 32.0% in the 1st quarter. Soros Capital Management LLC now owns 17,441 shares of the company’s stock valued at $2,872,000 after buying an additional 4,230 shares in the last quarter. 92.80% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on ZTS shares. UBS Group cut their price target on shares of Zoetis from $165.00 to $158.00 and set a “neutral” rating on the stock in a research note on Monday, October 20th. Argus reiterated a “buy” rating and set a $190.00 price target on shares of Zoetis in a research note on Tuesday, September 9th. Leerink Partnrs lowered shares of Zoetis from a “strong-buy” rating to a “hold” rating in a research note on Thursday, July 17th. Leerink Partners lowered shares of Zoetis from an “outperform” rating to a “market perform” rating and cut their price target for the stock from $180.00 to $155.00 in a research note on Thursday, July 17th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Zoetis in a research note on Friday. Four investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the stock. According to MarketBeat.com, the company has an average rating of “Hold” and a consensus target price of $195.00.

Zoetis Stock Down 0.2%

Shares of NYSE:ZTS opened at $146.14 on Monday. The stock has a market cap of $64.77 billion, a P/E ratio of 25.15, a P/E/G ratio of 2.35 and a beta of 0.90. The firm has a fifty day moving average price of $148.18 and a 200 day moving average price of $153.57. The company has a debt-to-equity ratio of 1.05, a current ratio of 1.76 and a quick ratio of 1.04. Zoetis Inc. has a 1-year low of $139.34 and a 1-year high of $184.40.

Zoetis (NYSE:ZTS) last issued its quarterly earnings results on Tuesday, August 5th. The company reported $1.76 earnings per share for the quarter, topping analysts’ consensus estimates of $1.62 by $0.14. The firm had revenue of $2.46 billion during the quarter, compared to analysts’ expectations of $2.41 billion. Zoetis had a net margin of 27.83% and a return on equity of 56.90%. Zoetis’s quarterly revenue was up 4.2% compared to the same quarter last year. During the same quarter in the prior year, the business earned $1.56 EPS. Zoetis has set its FY 2025 guidance at 6.300-6.400 EPS. Sell-side analysts predict that Zoetis Inc. will post 6.07 EPS for the current year.

Zoetis Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 2nd. Investors of record on Friday, October 31st will be paid a dividend of $0.50 per share. The ex-dividend date is Friday, October 31st. This represents a $2.00 dividend on an annualized basis and a yield of 1.4%. Zoetis’s dividend payout ratio is currently 34.42%.

Zoetis Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.